6505--Pylarify Injections

Award Notice Posted

Solicitation number
36C24625Q0224
Agency
Awarded
to Progenics Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36C24625D0035 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 has awarded contract 36C24625D0035 to Progenics Pharmaceuticals Inc. for Pylarify Injections, a radioactive diagnostic agent used for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. The contract, valued at $5,052,208.00, covers a 12-month base period from February 1, 2025, to January 31, 2026, with four additional 12-month option periods and a planned procurement of 280 annual doses. As the sole manufacturer and supplier of this specific PSMA imaging agent, Progenics Pharmaceuticals was selected through a sole source justification process after market research confirmed no alternative sources could meet the precise requirements for the radiopharmaceutical.

Notice text

Awarded contract 36C24625D0035 to PROGENICS PHARMACEUTICALS INC for 5052208.00 on 2025-01-31.

Files

File Type Posted
Justification _ redacted.pdf PDF
36C24625D0035_1.docx DOCX document

Notice history

Notice Type Posted
This notice Award Award Notice
6505--Pylarify Injections Latest special notice Special Notice

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Radiopharmaceuticals Base Plus Four Option Years VA San Diego Healthcare System Department of Veterans Affairs VA San Diego Healthcare System San Diego CA 92161 · NAICS 325412 Veterans Integrated Service Network 22 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors